Antidepressants Linked To Health Problems In Newborns

According the latest research, the women who are taking the antidepressant drugs that are known as selective serotonin reuptake inhibitors, who are pregnant or are willing to become pregnant must discuss their situation with their doctors because of the risks that these drugs pose to the baby.

They also added that the SSRI treatments must not be stopped prior to getting a consultation with their doctors, as the individuals might have an adverse reaction because of that, which is potentially serious.

The antidepressant treatment with the SSRIs should only be continued if the benefits outweigh the risks to the unborn child. It can also be considered as to switching to the other treatment option or stopping the treatment altogether.

The different antidepressant drugs that are prescribed to treat depression are as follows, which include Wellbutrin, Celexa, Prozac, Luvox, Paxil, Effexor etc.

The researchers suggested that the SSRIs when used during the second half of the pregnancy can cause persistent pulmonary hypertension of the newborn. The newborns who suffer from this condition do not receive enough oxygen in the blood and then they are admitted in the intensive care unit for the treatment to survive.

It has also been found that the babies who are born with these conditions is six times more in the babies who were exposed to SSRIs than the babies who were not exposed to this drug.

In another report it was also mentioned that the children who were exposed to SSRIs and other newer antidepressants during pregnancy could develop serious complications at birth. There is an increase in the overall risk of the major birth defects that has also been associated with the SSRI use.

The researchers stated that the side effects that occur due to the marketed products can be managed with the active participation of the health care professionals as well as the individuals who are using the medicines.


Leave a Reply